NanoCellect
22 employees on LinkedIn · 4 known investors
NanoCellect develops microfluidic-based cell sorters that operate at low pressure to sort cells with high viability and reduced shear stress, aimed at scientists and researchers. Its products use disposable, sterile microfluidic cartridges for applications such as single-cell sorting and stem cell research.
Founders & leadership
CN
Chris NearyinCEO
Investors · 4
Competitors · 3
by search overlapAbcam387 shared keywordsSupplier of protein research tools to life scientists. Publicly listed on the LSE following an IPO.
Danaher259 shared keywordsDanaher is a global science and technology company specializing in biotech, diagnostics, and life sciences with businesses that innovate in drug development, molecular diagnostics, genomic medicine, and bioprocessing to help advance human health. Operating through multiple strategic platforms and with nearly 63,000 employees, Danaher develops technologies and solutions for researchers, biopharmaceutical producers, and healthcare systems globally.
Fluorofinder220 shared keywordsFluoroFinder offers an AI-enabled platform for designing flow cytometry and fluorescent microscopy experiments, analyzing marker and fluorophore combinations across more than 3 million products from 78+ suppliers. It serves researchers, labs, and core facilities to select compatible reagents and plan experiments within their lab's configuration.
Companies competing with NanoCellect for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 16 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.8M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $224.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $214K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $224.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2014 | $1.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2014 | $976.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $691.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2012 | $972.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $199.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $698K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $289.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $198.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2010 | $166.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does NanoCellect do?
- NanoCellect develops microfluidic-based cell sorters that operate at low pressure to sort cells with high viability and reduced shear stress, aimed at scientists and researchers. Its products use disposable, sterile microfluidic cartridges for applications such as single-cell sorting and stem cell research.
- Who are NanoCellect's investors?
- NanoCellect's investors include Vertical Venture Partners, Warburg Pincus, FusionX Ventures, Illumina Ventures.